Celeste Krewson, Assistant Editor

Recent research delves into the repercussions of gestational diabetes mellitus on both maternal and perinatal health, shedding light on its effects in both singleton and twin pregnancies.

Recent findings revealed the efficacy and safety of the 2-step Graded Oral Challenge method in assessing penicillin allergy risk, offering a promising approach for improved patient care and antibiotic stewardship in low-risk individuals.

Delve into the intricate correlation between human chorionic gonadotropin levels during pregnancy and various adverse outcomes, shedding light on its multifaceted role in maternal-fetal health.

Adolescent pregnancy and sexual health care utilization declined during the COVID-19 pandemic, indicating significant disruptions in reproductive health services for young females, as highlighted in a recent study published in Pediatrics.

A comprehensive investigation uncovers the pervasive presence of endocrine-disrupting chemicals in menstrual hygiene items, potentially impacting gynecological and reproductive health.

A novel ultrasound technique allows for early and accurate prediction of preterm birth risk, potentially revolutionizing prenatal care for first-time pregnant women.

Delve into the dialogue surrounding women's cardiovascular health with Natalie Bello, MD, MPH, FACC, as she sheds light on the significance of American Heart Month and the impact of pregnancy on cardiovascular risk factors.

Recent research suggests strict abortion laws may deter applicants to obstetrics and gynecology residency programs, with implications for medical education and workforce diversity.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Recent research suggests that a deeper understanding of pregnancy correlates with a greater likelihood of opposing legislation limiting abortion access, shedding light on the role of education in shaping public opinion on reproductive rights.

A recent study revealed an 8.47-fold increased risk of suicide attempts among individuals with polycystic ovary syndrome, prompting the need for proactive mental health management in patients and improved tools for assessing health-related quality-of-life.

Nipocalimab, a monoclonal antibody targeting maternal alloantibodies, has received FDA Breakthrough Therapy Designation for treating severe hemolytic disease of the fetus and newborn.

Uncover the impact of maternal pre-pregnancy BMI on perinatal outcomes as elucidated by a multi-study investigation, shedding light on strategies to mitigate obstetric and neonatal risks through weight management.

A study revealed a correlation between maternal cortisol levels, stress, and adverse birth outcomes, shedding light on potential implications for perinatal health.

Disparities in prenatal care and missed opportunities for diagnosis highlight the need for innovative approaches to tackle the rising prevalence of congenital syphilis, emphasizing standardized screening, higher quality diagnostics, and therapeutic interventions.

A recent study highlighted how racial disparities, exacerbated by structural racism, impact the administration of neuraxial analgesia during labor, underscoring the need for interventions to address social inequity in maternal health care access.

A recent report from the Centers for Disease Control and Prevention outlined methods of detecting syphilis in patients, including nontreponemal tests, treponemal tests, and nonspecific antibodies.

A recent study found that transgender women with HIV face elevated risks of bacterial sexually transmitted infections, emphasizing the need for tailored interventions and further research to address the distinct challenges faced by this population.

A recent study found that the Gardasil quadrivalent HPV vaccine effectively shields HIV-positive adolescents from high-risk HPV types 16, 18, 6, and 11, shedding light on the potential for HPV vaccination to mitigate cancer risks in this vulnerable population.

Explore the Center for Disease Control of Prevention’s latest report on sexually transmitted infections, emphasizing the critical need for prioritizing STIs in public health.

Hologic's Genius Digital Diagnostics System, the first FDA-cleared digital cytology system using AI and advanced imaging, promises improved sensitivity in detecting pre-cancerous lesions and cervical cancer cells.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Uncover the latest findings on contraceptive methods as researchers delve into the safety, efficacy, and compliance rates of parenteral and oral hormonal contraceptives.

Preliminary findings suggest The Guardians mobile app, blending gaming and behavioral activation techniques, could be a solution for alleviating perinatal depression among pregnant women.

A phase 3 trial demonstrated that oteseconazole (VIVJOA; Mycovia Pharmaceuticals) capsules exhibit improved therapeutic and mycological cure rates to fluconazole for treating severe vulvovaginal candidiasis.

A systematic review of 6 studies revealed that COVID-19 vaccination during pregnancy does not significantly increase the risk of preterm birth, providing crucial insights for public health policies and offering reassurance to healthcare providers and expectant mothers.

A recent study revealed a 2-dose regimen of human papillomavirus vaccination in postpartum individuals is as effective as a 3-dose approach, providing valuable insights into optimizing vaccination strategies against the virus.

Dive into the latest research in metabolomics and proteomics, revealing potential biomarkers like fibrinogen cleavage peptides and GRAM domain-containing protein 1C, offering new avenues for diagnosis and treatment in addressing the global issue of female infertility.

New findings have revealed a decline in emergency contraception-related emergency department visits, indicating increased demand.

A recent study revealed that early postpartum administration of dexmedetomidine significantly reduces the risk of postpartum depression among women with prenatal depression.